SY-005 （Recombinant Human Annexin A5）in Patients With Sepsis

NCT04898322 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis

Interventions

DRUG: SY-005
DRUG: SY-005
DRUG: SY-005
DRUG: Placebo

Sponsor

Suzhou Yabao Pharmaceutical R&D Co., Ltd.